OT-730

DB16112InvestigationalSmall molecule

OT-730 is under investigation in clinical trial NCT00753168 (Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-angle Glaucoma).

Formula / weight: C₂₅H₃₆N₂O₈ · 492.569 g/mol (avg)
Code names: OT-730 · QLT-091568

Resolves to

Compound

UNII5WVS67PLALCAS870809-51-1

Structure

InChIKeyANXXSWNMHQHOQC-DJNXLDHESA-NSMILESCC1=CC(O)=C(O)C=C1C(=O)OC[C@H](CNC(C)(C)CNC(=O)C1CCOC1)OC(=O)C1(C)CC1

Targets

P13945ADRB3

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with OT-730, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account